Financhill
Back

CEL-SCI Quote, Financials, Valuation and Earnings

CEL-SCI Price Quote

$0.73
+0.00 (+-4.59%)
(Updated: December 21, 2024 at 5:22 AM ET)

CEL-SCI Key Stats

Buy
55
CEL-SCI (CVM) is a Buy

Day range:
$0.66 - $0.74
52-week range:
$0.49 - $3.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.5%

Volume:
817.2K
Avg. volume:
845.8K
1-year change:
-73.17%
Market cap:
$46.6M
Revenue:
$0
EPS:
$-0.58

How Much Does CEL-SCI Make?

Data Unavailable

Is CEL-SCI Growing As A Company?

Data Unavailable

CEL-SCI Stock Price Performance

  • Did CEL-SCI Stock Go Up Last Month?
    CEL-SCI share price went up by 16.23% last month
  • Did CVM's Share Price Rise Over The Last Year?
    CVM share price fell by -73.17% over the past 1 year

What Is CEL-SCI 52-Week High & Low?

  • What Is CEL-SCI’s 52-Week High Share Price?
    CEL-SCI has traded as high as $3.23 over the past 52 weeks
  • What Is CEL-SCI’s 52-Week Low Share Price?
    CEL-SCI has traded as low as $0.49 over the past 52 weeks

CEL-SCI Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CEL-SCI?

Data Unavailable

Is CEL-SCI Cash Flow Positive?

Data Unavailable

CEL-SCI Return On Invested Capital

Data Unavailable

CEL-SCI Earnings Date & Stock Price

  • What Is CEL-SCI's Stock Price Today?
    A single share of CVM can be purchased today for 0.73
  • What Is CEL-SCI’s Stock Symbol?
    CEL-SCI trades on the nyam under the ticker symbol: CVM
  • When Is CEL-SCI’s Next Earnings Date?
    The next quarterly earnings date for CEL-SCI is scheduled on February 14, 2025
  • When Is CVM's next ex-dividend date?
    CEL-SCI's next ex-dividend date is May 12, 2020
  • How To Buy CEL-SCI Stock?
    You can buy CEL-SCI shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CEL-SCI Competitors

  • Who Are CEL-SCI's Competitors?
    Below is a list of companies who compete with CEL-SCI or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)
    • Palatin Technologies Inc (PTN)

CEL-SCI Dividend Yield

Data Unavailable

CEL-SCI Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable